Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
Journal of the American College of Cardiology|November 14, 1997
Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registryW Kasper, S Konstantinides, A Geibel, et al.
Thrombosis and Haemostasis|April 8, 1998
Relation of urokinase-type plasminogen activator expression to presence and severity of atherosclerotic lesions in human coronary arteriesJ Kienast, T Padró, M Steins, et al.
Journal of Orthopaedic Surgery and Research|September 20, 2011
Biomechanical analysis of a synthetic femoral spiral fracture model: Do end caps improve retrograde flexible intramedullary nail fixation?Martin M Kaiser, Gregor Zachert, Robert Wendlandt, et al.
Circulation|August 5, 1997
Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registryS Konstantinides, A Geibel, M Olschewski, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1997
Treatment of deep vein thrombosis with low-molecular-weight heparins: a consensus statement of the Gesellschaft für Thrombose-und Hämostaseforschung (GTH)J Harenberg, U Schmitz-Huebner, K H Breddin, et al.
Mycoses|April 27, 2011
Current issues in the clinical management of invasive aspergillosis--the AGIHO, DMykG, ÖGMM and PEG web-based survey and expert consensus conference 2009M J G T Rüping, J J Vehreschild, A Groll, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2010
Management of sepsis in neutropenic patients: guidelines from the infectious diseases working party of the German Society of Hematology and OncologyO Penack, D Buchheidt, M Christopeit, et al.
The American Journal of Cardiology|May 1, 1988
Recombinant single-chain urokinase-type plasminogen activator during acute myocardial infarctionC Diefenbach, R Erbel, T Pop, et al.
International Journal of Hematology|October 7, 2008
AraU accumulation in patients with renal insufficiency as a potential mechanism for cytarabine neurotoxicityL H Lindner, H Ostermann, W Hiddemann, et al.
Oncology|October 17, 2002
Early tandem high-dose ifosfamide, carboplatin, etoposide therapy with stem cell rescue for small-cell lung cancer: brief report on the results of a phase-I/II trialE Oelmann, M Thomas, H Serve, et al.
Pageof 12